Literature DB >> 11713251

Ca2+/calmodulin-dependent protein kinase II is required for microcystin-induced apoptosis.

Kari E Fladmark1, Odd T Brustugun, Gunnar Mellgren, Camilla Krakstad, Roald Boe, Olav K Vintermyr, Howard Schulman, Stein O Doskeland.   

Abstract

The potent natural toxins microcystin, nodularin, and okadaic acid act rapidly to induce apoptotic cell death. Here we show that the apoptosis correlates with protein phosphorylation events and can be blocked by protein kinase inhibitors directed against the multifunctional Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). The inhibitors used comprised a battery of cell-permeable protein kinase antagonists and CaMKII-directed peptide inhibitors introduced by microinjection or enforced expression. Furthermore, apoptosis could be induced by enforced expression of active forms of CaMKII but not with inactive CaMKII. It is concluded that the apoptogenic toxins, presumably through their known ability to inhibit serine/threonine protein phosphatases, can cause CaMKII-dependent phosphorylation events leading to cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713251     DOI: 10.1074/jbc.M109049200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death.

Authors:  Sujuan Chen; Yijiao Xu; Baoshan Xu; Min Guo; Zhen Zhang; Lei Liu; Hongwei Ma; Zi Chen; Yan Luo; Shile Huang; Long Chen
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

2.  The role of CaMKII in calcium-activated death pathways in bone marrow B cells.

Authors:  Stephanie L Bissonnette; Amelia Haas; Koren K Mann; Jennifer J Schlezinger
Journal:  Toxicol Sci       Date:  2010-09-01       Impact factor: 4.849

Review 3.  CaMKII in the cardiovascular system: sensing redox states.

Authors:  Jeffrey R Erickson; B Julie He; Isabella M Grumbach; Mark E Anderson
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 4.  CaMKII in cerebral ischemia.

Authors:  Steven J Coultrap; Rebekah S Vest; Nicole M Ashpole; Andy Hudmon; K Ulrich Bayer
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

Review 5.  Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatases.

Authors:  A Ishida; N Sueyoshi; Y Shigeri; I Kameshita
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

6.  Epithelial cell apoptosis causes acute lung injury masquerading as emphysema.

Authors:  Majd Mouded; Eduardo E Egea; Matthew J Brown; Shane M Hanlon; A McGarry Houghton; Larry W Tsai; Edward P Ingenito; Steven D Shapiro
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

Review 7.  Molecular mechanisms of microcystin toxicity in animal cells.

Authors:  Alexandre Campos; Vitor Vasconcelos
Journal:  Int J Mol Sci       Date:  2010-01-21       Impact factor: 6.208

8.  The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.

Authors:  Eun-Young Ahn; George Pan; Jae Hwan Oh; Ewan M Tytler; Jay M McDonald
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.

Authors:  Hamid R Samari; Michael T N Møller; Lise Holden; Tonje Asmyhr; Per O Seglen
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

10.  Dual mechanism of a natural CaMKII inhibitor.

Authors:  Rebekah S Vest; Kurtis D Davies; Heather O'Leary; J David Port; K Ulrich Bayer
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.